Ciara Higgins
About Ciara Higgins
Ciara Higgins serves as the Senior Director of Business Operations at Adaptimmune, where she has worked since 2022. She has extensive experience in project management and operations within the biotechnology sector, having held various roles at Adaptimmune and ICON plc.
Current Role at Adaptimmune
Ciara Higgins serves as the Senior Director of Business Operations at Adaptimmune, a position she has held since 2022. In this role, she oversees various business operations, ensuring efficient processes and strategic alignment within the organization. Her extensive experience in project management and operations contributes to her leadership in driving business objectives.
Previous Positions at Adaptimmune
Ciara Higgins has held multiple positions at Adaptimmune, starting as a Clinical Project Manager from 2013 to 2017. She then progressed to Associate Director of Pipeline Management for five months in 2017, followed by Associate Director of Project Management from 2017 to 2019. She served as Director of Business Operations from 2020 to 2022 before her current role. Her tenure at Adaptimmune spans various leadership roles, reflecting her expertise in project and business management.
Education and Expertise
Ciara Higgins earned her PhD in Nutritional Metabolomics from University College Dublin, where she studied from 2008 to 2012. Prior to that, she completed her undergraduate studies in Human Nutrition at Queen's University Belfast, achieving a degree focused on Food Quality, Safety, and Nutrition from 2005 to 2008. Her educational background equips her with a strong foundation in nutrition and metabolomics, which supports her work in the biopharmaceutical sector.
Experience at ICON plc
Before joining Adaptimmune, Ciara Higgins worked at ICON plc as a Project Manager from 2012 to 2013. In this role, she managed various projects within the clinical research environment, contributing to her skills in project management and operational efficiency. This experience laid the groundwork for her subsequent roles in the biopharmaceutical industry.